Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical glyceryl trinitrate patch for radial artery dilation before neonatal arterial cannulation
ACTRN12623000509662Phase 2Completed
- Sponsor
- Perth Children's Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of nitroglycerin in None and critical illness (4 arms), sponsored by Perth Children's Hospital. Primary endpoint: Change from baseline in radial artery diameter. Started Aug 2023; status: completed.
02
Drugs
nitroglycerin
03
Conditions
critical illness
Beyond the preview
Go deeper on ACTRN12623000509662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000509662.